Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-22.6%
5Y CAGR-30.7%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-22.6%/yr
vs -2.0%/yr prior
5Y CAGR
-30.7%/yr
Recent acceleration
Acceleration
-20.6pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 8.20% |
| 2024 | 10.25% |
| 2023 | 9.64% |
| 2022 | 17.69% |
| 2021 | 21.96% |
| 2020 | 51.29% |
| 2019 | 37.04% |
| 2018 | 19.18% |
| 2017 | 48.39% |
| 2016 | 64.50% |